United Kingdom· GB-APID-44145011000001104
Baricitinib 2mg tablets
A baricitinib product containing baricitinib, registered in United Kingdom by Eli Lilly and Company Ltd. The same ATC class is registered in 13 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Baricitinib is registered in 13 of 19 countries.
Countries holding a registration under ATC L04AF02 (baricitinib), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 7 of them publish a price we can compare per daily dose
Baricitinib · ATC L04AF02
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of baricitinib costs, country by country.
Normalised to the WHO defined daily dose (3 mg), the median price runs from $26.41 in France to $138.66 in United States — a ×5.2 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Baricitinib · price per daily dose (3 mg)
USD · FX 28 Sept 2026
- US United States$138.66 (acquisition cost)
- CH Switzerland$62.27
- FR France$26.41
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Baricitinib
- Manufacturer
- Eli Lilly and Company Ltd
- Country
- United Kingdom (GB)
- ATC code
- L04AF02
- ATC class
- Baricitinib
- Defined daily dose
- 3 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5014602401399
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
368 interactions on record for baricitinib.
Graded by severity as the source publishes them — 295 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Baricitinib · interactions on record
368 records
- 295 severe
- 67 moderate
- 6 minor
Most severe, free to view
- PrednisoloneA07EA01severe
- HydrocortisoneA07EA02severe
- PrednisoneA07EA03severe
- BetamethasoneA07EA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Baricitinib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaOLUMIANTELI LILLY CANADA INC
- CzechiaOLUMIANTEli Lilly Nederland B.V., Utrecht
- United StatesBaricitinibEli Lilly and Company
- FinlandOlumiantEli Lilly Nederland B.V
- NetherlandsOlumiant 1 mg, filmomhulde tablettenEli Lilly Nederland B.V.
- BelgiumOlumiant 1 mgEli Lilly Nederland
- SwedenOlumiant 1 mg Filmdragerad tablettEli Lilly Nederland B.V.
- IrelandOlumiant 1 mg film-coated tabletsEli Lilly Nederland B.V.
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Iceland · Olumiant
- Liechtenstein · Olumiant
- Norway · Olumiant
- Portugal · Baricitinib Generis
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/725189ff-21e5-4e95-aa6e-61c63577a5e8 GET /v1/drugs/725189ff-21e5-4e95-aa6e-61c63577a5e8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "44145011000001104",
"desc": "Baricitinib 2mg tablets (Eli Lilly and Company Ltd)",
"form": "Oral tablet",
"vpid": "34625211000001109",
"source": "dmd",
"vtm_id": "774738004",
"strength": "2 mg",
"substance": "Baricitinib",
"ingredient": "Baricitinib",
"supplier_code": "2075101000001100"
}See everything about baricitinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.